Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020

View ORCID ProfileV Hall, View ORCID ProfileS Foulkes, View ORCID ProfileA Charlett, View ORCID ProfileA Atti, View ORCID ProfileEJM Monk, View ORCID ProfileR Simmons, E Wellington, View ORCID ProfileMJ Cole, View ORCID ProfileA Saei, View ORCID ProfileB Oguti, K Munro, S Wallace, View ORCID ProfilePD Kirwan, View ORCID ProfileM Shrotri, View ORCID ProfileA Vusirikala, S Rokadiya, View ORCID ProfileM Kall, M Zambon, M Ramsay, T Brooks, SIREN Study Group, CS Brown, MA Chand, S Hopkins
doi: https://doi.org/10.1101/2021.01.13.21249642
V Hall
1COVID-19 response, Public Health England, UK
2The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V Hall
  • For correspondence: Susan.Hopkins{at}phe.gov.uk
S Foulkes
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S Foulkes
A Charlett
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Charlett
A Atti
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Atti
EJM Monk
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for EJM Monk
R Simmons
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R Simmons
E Wellington
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MJ Cole
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for MJ Cole
A Saei
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Saei
B Oguti
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for B Oguti
K Munro
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Wallace
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PD Kirwan
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for PD Kirwan
M Shrotri
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M Shrotri
A Vusirikala
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A Vusirikala
S Rokadiya
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Kall
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M Kall
M Zambon
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Ramsay
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Brooks
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CS Brown
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MA Chand
1COVID-19 response, Public Health England, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Hopkins
1COVID-19 response, Public Health England, UK
2The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background There is an urgent need to better understand whether individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection.

Methods A large multi-centre prospective cohort was recruited from publicly funded hospital staff in the UK. Participants attended regular SARS-CoV-2 PCR and antibody testing (every 2-4 weeks) and completed fortnightly questionnaires on symptoms and exposures. At enrolment, participants were assigned to either the positive cohort (antibody positive or prior PCR/antibody test positive) or negative cohort (antibody negative, not previously known to be PCR/antibody positive). Potential reinfections were clinically reviewed and classified according to case definitions (confirmed, probable, possible (subdivided by symptom-status)) depending on hierarchy of evidence. Individuals in the primary infection were excluded from this analysis if infection was confirmed by antibody only. Reinfection rates in the positive cohort were compared against new PCR positives in the negative cohort using a mixed effective multivariable logistic regression analysis.

Findings Between 18 June and 09 November 2020, 44 reinfections (2 probable, 42 possible) were detected in the baseline positive cohort of 6,614 participants, collectively contributing 1,339,078 days of follow-up. This compares with 318 new PCR positive infections and 94 antibody seroconversions in the negative cohort of 14,173 participants, contributing 1,868,646 days of follow-up. The incidence density per 100,000 person days between June and November 2020 was 3.3 reinfections in the positive cohort, compared with 22.4 new PCR confirmed infections in the negative cohort. The adjusted odds ratio was 0.17 for all reinfections (95% CI 0.13-0.24) compared to PCR confirmed primary infections. The median interval between primary infection and reinfection was over 160 days.

Interpretation A prior history of SARS-CoV-2 infection was associated with an 83% lower risk of infection, with median protective effect observed five months following primary infection. This is the minimum likely effect as seroconversions were not included.

Funding Department of Health and Social Care and Public Health England, with contributions from the Scottish, Welsh and Northern Irish governments.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ISRCTN11041050

Funding Statement

The study is funded by the UK Department of Health and Social Care and Public Health England with contributions from the Scottish, Welsh and Northern Irish governments Funding is also provided by the National Institute for Health Research as an Urgent Public Health Priority Study SH & VH are supported by the National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England NIHR200915.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Berkshire Research Ethics Committee Health Research Authority and Health and Care Research Approval Wales granted 22 May 2020. IRAS ID 284460

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • SIREN study group∞ contributors listed below

Data Availability

Data will be available to trusted researchers once the final study data is released.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020
V Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, MJ Cole, A Saei, B Oguti, K Munro, S Wallace, PD Kirwan, M Shrotri, A Vusirikala, S Rokadiya, M Kall, M Zambon, M Ramsay, T Brooks, SIREN Study Group, CS Brown, MA Chand, S Hopkins
medRxiv 2021.01.13.21249642; doi: https://doi.org/10.1101/2021.01.13.21249642
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020
V Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, MJ Cole, A Saei, B Oguti, K Munro, S Wallace, PD Kirwan, M Shrotri, A Vusirikala, S Rokadiya, M Kall, M Zambon, M Ramsay, T Brooks, SIREN Study Group, CS Brown, MA Chand, S Hopkins
medRxiv 2021.01.13.21249642; doi: https://doi.org/10.1101/2021.01.13.21249642

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)